Lipid Droplets Reframe Macrophage Resolution as a Metabolic Decision
Macrophage biology in this review turns on a deceptively simple question: when does a lipid droplet help resolution, and when does it trap the cell inside chronic inflammation? The answer is not binary. Lipid droplets are presented as active organelles that regulate free cholesterol and fatty acids, shape immune signaling, and determine whether macrophages move toward clearance or stall in a pro-inflammatory state. In that framing, droplet accumulation is not automatically harmful. It can be adaptive early in inflammation, especially when a macrophage needs to sequester lipotoxic free cholesterol and fatty acids. The problem begins when turnover fails and the cell can no longer convert lipid handling into pro-resolving function.
That shift carries direct relevance for autoimmune disease, atherosclerosis, obesity-associated inflammation, cancer, and infection. The review repeatedly returns to the same principle: macrophage metabolism is not separate from immune function. It is the machinery that makes resolution possible.
Efferocytosis Sets the Tone for Lipid Handling
A central thread is efferocytosis, the engulfment of apoptotic cells and debris. Successful clearance does more than remove dying cells. It delivers lipid cargo that is processed into free fatty acids and cholesterol, which can then be esterified, effluxed, stored, or oxidized. A single efferocytic event can nearly double the macrophage’s plasma-membrane cholesterol load, so the cell must respond quickly or risk toxicity. When the response is intact, cholesterol-derived liver X receptor ligands induce both MerTK and ABCA1, reinforcing recognition and efflux at the same time.
Resolution therefore becomes self-propagating. Efferocytosis stimulates PPARδ and PPARγ signaling, which supports production of C1q, TGF-β, IL-10, and specialized pro-resolving mediators. In practical terms, one successful clearance event primes the next. The macrophage becomes more capable of resolving the inflammatory burden it encounters later.
A failed clearance event moves the system in the opposite direction.
Uncleared apoptotic cells expose damage-associated molecular patterns, nuclear autoantigens, and nucleic acids that can intensify autoimmune responses. In systemic lupus erythematosus, that biology is especially consequential because failed clearance is tied to anti-nuclear autoantibodies and type I interferon responses. The review also links defective efferocytosis to lupus-like phenotypes in mice when bridging molecules or phosphatidylserine-recognition machinery are disrupted.
Lipid Droplet Enzymes Act as Switches in the Resolution Circuit
The review places unusual emphasis on the proteins that coat and remodel the droplet. Perilipin family proteins such as PLIN2 and PLIN3 regulate access to the lipid core, while a neutral-lipase relay involving ATGL, HSL, and MAGL determines whether stored triacylglycerol is mobilized. On the cholesterol side, ACAT1/SOAT1 esterification and NCEH1/LAL hydrolysis set the free-cholesterol balance that governs stress responses in the endoplasmic reticulum.
These enzymes are presented as molecular switches, not passive markers. ATGL controls the initial mobilization of droplet triacylglycerol, while HSL has already been linked to efficient efferocytosis and acquisition of an M2-like, resolution-competent macrophage phenotype. Loss of HSL shifts macrophages toward a pro-inflammatory, clearance-deficient state. That observation is especially important because it suggests that droplet turnover is not just a storage issue; it is part of the engulfment program itself.
Therapeutic translation, however, is not straightforward. ATGL, HSL, MAGL, ACAT1/SOAT1, and LAL act broadly across tissues, so global modulation could raise circulating free fatty acids or create lipotoxicity in off-target organs. The review argues that any attempt to manipulate this machinery will require macrophage-selective strategies rather than systemic lipase control.
Inflammatory Signals Drive Droplet Accumulation Through a Metabolic Rewire
The review describes pro-inflammatory activation as a switch that inverts the macrophage–lipid droplet relationship. IFNγ and Toll-like receptor ligands push macrophages toward an M1-like state, shifting metabolism away from oxidative phosphorylation and toward glycolysis. iNOS-derived nitric oxide then helps drive lipid accumulation through two linked mechanisms. First, it disrupts mitochondrial metabolism by targeting aconitase 2 and impairing the TCA cycle, reducing fatty-acid catabolism and favoring esterification into triacylglycerols and cholesterol esters. Second, it promotes degradation of LXRα, which lowers ABCA1 expression and weakens cholesterol efflux.
The effect is a double hit. Recognition falls because MerTK and ABCA1 are co-induced by LXR, while export of excess cholesterol also falters. Lipid droplets then accumulate as a consequence of failed disposal, not as an isolated abnormality. Their presence signals that the macrophage has lost metabolic flexibility.
Lipid Loading Impairs Recognition, Engulfment, and Digestion
The review breaks efferocytosis into three vulnerable stages: recognition, engulfment, and digestion.
Recognition is compromised when hypercholesterolemia and oxidized phospholipids activate ADAM17, which cleaves MerTK and releases soluble Mer. Surface receptor loss and soluble Mer activity together suppress efferocytosis and pro-resolving mediator biosynthesis. Elevated soluble Mer in active systemic lupus erythematosus ties this pathway to human disease activity.
Engulfment is constrained by the physical presence of lipid droplets. Because droplets are relatively rigid, they can displace the apical actomyosin cytoskeleton and interfere with the membrane remodeling needed for phagocytosis. Mechanical compression or stretching can reverse that suppression, suggesting a biophysical component to the defect. Free cholesterol adds another layer of injury by inhibiting ACAT1, allowing unesterified cholesterol to accumulate and drive endoplasmic reticulum stress. ATF4, TRIB3, Rab27a, and the PERK–CHOP arm then interfere with phagosome closure and macrophage survival.
Digestion fails when lipophagy and autophagy break down. After engulfment, lipophagy normally delivers droplets to lysosomes, where lysosomal acid lipase frees cholesterol for ABCA1-mediated efflux. Chronic lipid loading disrupts this pathway. Atg5 deficiency, in particular, is linked to NLRP3 inflammasome activation, oxidative stress, and defective efferocytosis.
The Same Circuit Appears in Obesity-Linked Macrophage States
The review extends beyond atherosclerotic foam cells to adipose tissue macrophages. In obesity, dying adipocytes are surrounded by macrophages in crown-like structures, and those cells can adopt a lipid-associated phenotype marked by TREM2. The implication is broader than one disease site: whenever lipid supply exceeds disposal, macrophages may enter a state defined by droplet accumulation, altered engulfment, and incomplete resolution.
Here the review’s key message is concrete. Lipid droplets are not inert storage bodies. They are part of the machinery that decides whether a macrophage resolves inflammation or perpetuates it. The unresolved issue is how to exploit droplet turnover therapeutically without worsening systemic lipid toxicity, since the enzymes that regulate this pathway are not macrophage-exclusive and the balance between adaptive and maladaptive droplet formation depends on inflammatory phase, polarization state, and tissue niche.